VUOTO ANTHONY 4

4 · IRADIMED CORP · Filed Dec 8, 2022

Form 4

Period: 2022-12-07

Director

Transactions

Exercise/Conversion
Common Stock
[F1]
2022-12-07+2,037→ 16,158 total
Exercise/Conversion
Common Stock
[F1]
2022-12-07+1,035→ 17,193 total
Exercise/Conversion
Restricted Stock Units
[F1][F3]
2022-12-07−2,037→ 0 total
→ Common Stock (2,037 underlying)
Exercise/Conversion
Restricted Stock Units
[F1][F4]
2022-12-07−1,035→ 1,036 total
→ Common Stock (1,035 underlying)
Award
Restricted Stock Units
[F2][F5]
2022-12-07+3,501→ 4,537 total
→ Common Stock (3,501 underlying)

Footnotes (5)

[F1]Restricted stock units convert into common stock on a one-for-one basis.
[F2]Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.
[F3]The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
[F4]On December 7, 2021, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
[F5]On December 7, 2022, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Signature

/s/ Anthony Vuoto|2022-12-08

Documents

1 file